Maternal age-specific risks for trisomies at 9—14 weeks' gestation

This study provides data on the incidence of fetal trisomies 21, 18, and 13 at 9–14 weeks' gestation in women aged 35–45 years and estimates of maternal age-specific risks in women aged 20–45 years. Our data from 5814 singleton pregnancies undergoing first-trimester karyotyping for the sole indication of maternal age ⩾ 35 years were combined with those from two previous reports and the incidence of the trisomies was calculated from a total of 15 793 pregnancies. Comparison of incidences at 9–14 weeks' gestation with published data at 15–20 weeks' gestation and in livebirths demonstrated that at birth the maternal age-specific incidence of trisomy 21 is 33 per cent lower than at 15–20 weeks' gestation and 54 per cent lower than at 9–14 weeks' gestation. Furthermore, the relative frequency of trisomies 18 and 13 decreases from 30 per cent at 9–14 weeks to 22 per cent at 15–20 weeks and 14 per cent at birth.     

Dystrophin protein and rflp analyis for fetal diagnosis and carrier confirmation of duchenne muscular dystrophy

A pregnant woman with indeterminate Duchenne muscular dystrophy (DMD) carrier status, but with DMD diagnosed in her deceased brother (unavailable for study), presented for prenatal diagnosis, intending to continue the pregnancy only if proven unaffected with DMD with near absolute certainty. Creatine kinase (CK) assays to clarify carrier status were inconclusive. Male sex in the fetus was identified, but DNA restriction fragment length polymorphism (RFLP) analysis was not yet available to this centre to investigate the possible transmission of the DMD gene, and the pregnancy was terminated. Tissue histology and dystrophin protein analysis demonstrated the absence of DMD. In a situation with proven maternal carrier status, future fetal inheritance of the opposite maternal X chromosome would indicate the presence of DMD. However, maternal carrier status remained in doubt through a second pregnancy, even with RFLP studies, and was finally established when dystrophin analysis confirmed the presence of DMD in the second fetus. Histologic findings are presented, contrasting features in the two fetuses. The value of dystrophin analysis for establishing the diagnosis of fetal DMD, in this case proving maternal carrier status in a difficult situation, and for demonstrating DMD gene:RFLP haplotype relationships is illustrated.     

Prenatal diagnosis of endocardial fibroelastosis

In a case of fetal heart failure caused by endocardial fibroelastosis, prenatal echocardiography clearly demonstrated; a thickened endocardium. We therefore suggest that an abnormal endocardium may be detected in utero by ultrasound, thus representing an important clue in the differential diagnosis of fetal nonimmune hydrops and in the evaluation of pregnancies at risk for endocardial fibroelastosis.     

炼铁高炉净环水高pH碱性运行的阻垢缓蚀研究

以某炼铁高炉妆环水为对象，对循环冷却水高ＰＨ碱性运行阻垢缓蚀进行了研究，筛选出了一复合配方。工业应用试验结果表明，此配方对Ａ３钢的污垢附着速率，腐蚀速率和污垢热阻均低于国家规定的指标要求，说明该配方具有良好的阻垢缓蚀性能。     

Hepatic calcifications in a fetus with trisomy 9 that underwent cordocentesis

Foci of calcification were observed at autopsy in the liver of a fetus with complete trisomy 9 on which two cordocenteses had been performed. It is suggested that liver calcifications are a possible complication of the procedure. As several other cases of calcifications in the liver and other organs of fetuses with autosomal trisomies have been described without a history of cordocentesis, further studies should be carried out to determine whether fetuses with chromosomal anomalies are more prone to thrombus formation and embolization.     

一种新型复合式生物流化反应器混合特性的研究

对新型蜂窝状断面复合生物流化反应器进行了液体循环速率和水力停留时间分布曲线的测定，实验表明新型反应器具有抗冲击负荷强，接近CSTR反应器的特点，反应器随气量增大、载体投加量减少和进水量减少而更近似于CSTR反应器，通过理论分析，证明了影响液体循环速率的参数主要有气体流量(气含率)、反应器沿程和局部阻力系数以及Ad/Ar，并且得出液体循环速率与反应器高度的0．5次方成正比。     

PASS混凝去除给水腐植酸的研究

用所研制的聚硅硫酸铝对含腐植酸原水进行了混凝处理 ,研究了投加量、pH值等对腐植酸去除效果的影响 ,探讨了PASS对腐植酸的混凝去除机理 ,并作了经济分析     

冲天炉除尘循环水的处理

介绍冲天炉除尘洗涤循环水处理工艺过程，包括絮凝沉淀，SO2的吸收，循环水冷却、水质稳定，污泥脱水等过程。     

循环流化床锅炉床温控制方法

就目前电厂循环流化床锅炉运行中存在的床温波动问题，讨论了导致床温波动的因素，并针对性地提出了控制床温的一些措施。     

仪化热电厂提高循环水浓缩倍率的措施

针对仪化热电厂将循环水用作冲灰水，导致浓缩倍率只有1.6，以及凝汽器铜管腐蚀结垢严重等问题，提出了隔断循环水与冲灰水的直接联系，实现闲路循环，对凝汽器铜管进行酸洗，并对循环水实施加缓蚀阻垢荆、杀菌剂和旁流过滤等办法，全部实施后产生了很好的效益，值得借鉴。